Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120


Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.

Kang DW, Hwang WC, Park MH, Ko GH, Ha WS, Kim KS, Lee YC, Choi KY, Min DS.

Oncogene. 2013 Jul 25;32(30):3531-42. doi: 10.1038/onc.2012.358. Epub 2012 Aug 13.


Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.

Kang DW, Noh YN, Hwang WC, Choi KY, Min do S.

Biochem Pharmacol. 2016 Aug 1;113:36-44. doi: 10.1016/j.bcp.2016.06.003. Epub 2016 Jun 2.


The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.

Yoshida N, Ishikawa T, Ichiishi E, Yoshida Y, Hanashiro K, Kuchide M, Uchiyama K, Kokura S, Ichikawa H, Naito Y, Yamamura Y, Okanoue T, Yoshikawa T.

Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:63-75.


Protective effect of rebamipide against Helicobacter pylori-CagA-induced effects on gastric epithelial cells.

Lee KH, Kim JY, Kim WK, Shin DH, Choi KU, Kim DW, Lee WJ, Choi JH, Lee SH, Kim GH, Song GA, Jeon TY, Kim CD, Hong KW, Park DY.

Dig Dis Sci. 2011 Feb;56(2):441-8. doi: 10.1007/s10620-010-1299-x. Epub 2010 Jun 16.


Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.

Masamune A, Yoshida M, Sakai Y, Shimosegawa T.

J Pharmacol Exp Ther. 2001 Aug;298(2):485-92.


Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.

Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K.

Dig Dis Sci. 1998 Sep;43(9 Suppl):174S-180S.


Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.

Hayashi S, Sugiyama T, Amano K, Isogai H, Isogai E, Aihara M, Kikuchi M, Asaka M, Yokota K, Oguma K, Fujii N, Hirai Y.

Antimicrob Agents Chemother. 1998 Aug;42(8):1895-9.


Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.

Hayashi S, Sugiyama T, Yokota K, Isogai H, Isogai E, Shimomura H, Oguma K, Asaka M, Hirai Y.

Microbiol Immunol. 2000;44(7):557-62.


H. pylori-encoded CagA disrupts tight junctions and induces invasiveness of AGS gastric carcinoma cells via Cdx2-dependent targeting of Claudin-2.

Song X, Chen HX, Wang XY, Deng XY, Xi YX, He Q, Peng TL, Chen J, Chen W, Wong BC, Chen MH.

Cell Immunol. 2013 Nov-Dec;286(1-2):22-30. doi: 10.1016/j.cellimm.2013.10.008. Epub 2013 Nov 9.


Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.

Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, Hu CJ, Dong H, Yang SM.

Cancer Lett. 2016 May 1;374(2):292-303. doi: 10.1016/j.canlet.2016.02.032. Epub 2016 Mar 2.


Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.

Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M.

Gut. 1994 Oct;35(10):1375-8.


Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.

Zhang BG, Hu L, Zang MD, Wang HX, Zhao W, Li JF, Su LP, Shao Z, Zhao X, Zhu ZG, Yan M, Liu B.

Oncotarget. 2016 Mar 1;7(9):9788-800. doi: 10.18632/oncotarget.7125.


Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.

Hahm KB, Kim DH, Lee KM, Lee JS, Surh YJ, Kim YB, Yoo BM, Kim JH, Joo HJ, Cho YK, Nam KT, Cho SW.

Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:24-38.


Interaction of omeprazole and Helicobacter pylori-induced nuclear factor-κB activation and mediators in gastric epithelial cells.

Peng YC, Huang LR, Shyu CL, Cheng CC, Ho SP.

J Chin Med Assoc. 2014 Nov;77(11):567-72. doi: 10.1016/j.jcma.2014.07.006. Epub 2014 Sep 7.


Caffeic acid phenethyl ester downregulates phospholipase D1 via direct binding and inhibition of NFκB transactivation.

Park MH, Kang DW, Jung Y, Choi KY, Min do S.

Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):1-7. doi: 10.1016/j.bbrc.2013.09.105. Epub 2013 Oct 5.


Supplemental Content

Support Center